查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941771

美国持续正压呼吸器（CPAP）市场规模、销售、平均售价趋势、份额和预测分析报告：按性别、最终用途和细分市场预测（2026-2033 年）

U.S. Continuous Positive Airway Pressure Devices Market Size, Unit Volume, Average Selling Price Trends, Share & Forecast Analysis Report, By Connectivity, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国持续正压呼吸器市场概述

据估计，2025 年美国持续正压呼吸器(CPAP) 市值为 13.5 亿美元，预计到 2033 年将达到 20.7 亿美元。

预计从 2026 年到 2033 年，该行业将以 5.50% 的复合年增长率增长，这主要得益于睡眠呼吸中止症和呼吸系统疾病的患病率上升、持续正压呼吸器的技术进步、人们对睡眠呼吸中止症的认识和诊断不断提高，以及有利的报销政策。

例如，联邦医疗保险（Medicare）为被诊断患有阻塞型睡眠呼吸中止症的患者提供三个月的持续性正压呼吸器（CPAP）设备及其配件试用期。由于肥胖、久坐的生活方式和人口老化等因素，睡眠呼吸中止症和其他呼吸系统疾病在美国的发病率正在上升。根据美国疾病管制与预防中心（CDC）2024年5月发布的估计数据，2021年8月至2023年8月期间，美国成年人的肥胖率将达到40.3%，男女之间没有显着差异。 41至60岁成年人的肥胖率高于20至39岁以及60岁以上的人。肥胖率的上升显着加剧了睡眠呼吸中止症的盛行率，进而推动了对CPAP设备的需求。

此外，CPAP技术的不断创新显着提高了患者的舒适度和治疗效果。现代CPAP呼吸机配备了更安静的马达、更紧凑的设计、整合式加湿系统和先进的数据追踪功能。这些改进解决了患者常见的噪音和不适感等问题，从而提高了治疗依从性。

政府卫生机构和非营利组织经常进行宣传活动，向公众普及睡眠呼吸中止症及其治疗的必要性。例如，2024年5月，美国疾病管制与预防中心（CDC）将睡眠呼吸中止症纳入了一项更广泛的公共卫生宣传活动，该活动旨在改善睡眠卫生并促进慢性病管理。

在美国，租赁模式在推广持续正压呼吸器的使用方面发挥关键作用，同时也影响CPAP设备的定价和收入结构。 CPAP设备通常以「先租后买」的方式提供给患者，租期为10-13个月，具体期限取决于保险报销政策，主要包括联邦医疗保险（Medicare）和私人保险公司的报销政策。这种模式透过降低患者的前期成本、提高治疗启动率以及使保险公司能够在患者完全拥有设备之前核实其治疗依从性，从而有助于提高市场渗透率。

然而，这种方法会延迟製造商即时确认设备销售收入，将购买力转移到医疗设备供应商，并增加长期病患依从性、远端监控和更换週期（面罩、导管、过滤器等）的重要性。 CPAP 租赁正在促进美国持续阳压呼吸器(CPAP) 设备产业的稳定持续需求、提高价格敏感性，并更加重视连网设备和基于服务的差异化。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场趋势与展望
  • 市场动态
  • 美国CPAP设备市场分析工具：PESTEL分析法
    • 政治/法律法规
    • 经济与社会
    • 科技
    • 环境
  • 美国CPAP市场分析工具：波特五力分析

第四章：美国CPAP设备市场：连结性估算与趋势分析

  • 美国CPAP设备市场：连结性差异分析
  • 2025 年和 2033 年连结性变化分析与市占率分析
  • 美国连结市场估算与预测（按连结类型划分）
  • 连接类型
    • 蓝牙连接的CPAP
    • 支援Wi-Fi和蜂窝网路连接的CPAP呼吸机
    • 混合连接
  • 未连接

第五章 美国CPAP设备市场：依最终用途分類的估算与趋势分析

  • 美国CPAP设备市场：最终用途差异分析
  • 按最终用途分類的变化分析和市场份额分析（2025 年和 2033 年）
  • 美国CPAP设备市场：按最终用途分類的估算和预测
  • 居家医疗环境
  • 医院和诊所
  • 其他（长期照护机构等）

第六章 竞争情势

  • 公司分类
  • Strategies of Market Players for Entry and Exit and Their Impact on Market Competitors
  • 企业市场分析
  • Company Share Analysis, from 2012 to 2025（%）
  • 公司简介/上市资讯
    • ResMed
    • Koninklijke Philips NV
    • Fisher &Paykel Healthcare Limited
    • React Health（3B Medical）
    • Lowenstein Medical
    • BMC Medical
    • Wellell（Apex Medical）
    • Armstrong Medical
    • Breas Medical
    • SEFAM
    • Transcend Inc.（Somnetics International, Inc.）
    • Trudell Medical（Vyaire）
    • Medical Depot, Inc. dba Drive DeVilbiss Healthcare
    • Invacare Corporation
    • Apria Healthcare Group LLC
    • Rotech Healthcare Inc.
    • Others
  • US CPAP Devices：Sales Model Composition（Rental vs. Direct Purchase）, 2020-2024
  • US PAP Device DME Distributor-Level Profiles
    • 林卡控股有限公司
    • Rotec Healthcare Co., Ltd.
    • AdapHealth
    • Aeroflow Health
    • CPAPeople.com
    • AHOM
    • CPAP商店
    • Sleep Direct
    • 埃奇帕克医疗用品
    • Apria Healthcare
Product Code: GVR-4-68040-556-8

U.S. Continuous Positive Airway Pressure Devices Market Summary

The U.S. continuous positive airway pressure devices market size was estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.07 billion by 2033, growing at a CAGR of 5.50% from 2026 to 2033. This is attributed to the rising prevalence of sleep apnea and respiratory disorders, technological advancements in continuous positive airway pressure devices (CPAP) devices, growing awareness and diagnosis of sleep apnea, and favorable reimbursement policies.

For instance, Medicare covers a 3-month trial of CPAP devices and accessories for individuals diagnosed with obstructive sleep apnea. The incidence of sleep apnea and other respiratory disorders is on the rise in the U.S., primarily due to factors such as obesity, sedentary lifestyles, and an aging population. According to the Centers for Disease Control and Prevention (CDC) estimates published in May 2024, between August 2021 and August 2023, the obesity rate among adults was 40.3%, with no notable differences between women & men. Obesity was higher in adults aged 41-60 compared to those aged 20-39 and those 60 and older. This growing obesity rate contributes significantly to the increasing prevalence of sleep apnea, thereby driving the demand for CPAP devices.

Moreover, continuous innovations in CPAP technology have significantly enhanced patient comfort and therapy effectiveness. Modern CPAP machines feature quieter motors, compact designs, integrated humidification systems, and advanced data-tracking capabilities. These improvements address common patient concerns, such as noise and discomfort, thereby increasing therapy adherence rates.

Government health agencies and non-profit organizations frequently conduct public awareness initiatives to inform individuals about sleep apnea and treatment needs. For instance, in May 2024, the CDC in the U.S. incorporated sleep apnea into its broader public health campaigns on sleep hygiene and the management of chronic diseases.

The rental model plays a significant role in shaping the adoption of continuous positive airway pressure devices in the U.S., as well as pricing and revenue dynamics. CPAP devices are commonly provided to patients on a rent-to-own basis, typically over a 10 to 13-month period, driven largely by insurance reimbursement policies, including those of Medicare and private payers. In addition, this model reduces upfront costs for patients, enhances therapy initiation rates, and enables payers to verify compliance before full ownership, thereby facilitating broader market penetration.

However, it also slows immediate device sales revenue recognition for manufacturers, shifts purchasing power toward DME providers, and increases the importance of long-term patient adherence, remote monitoring, and replacement cycles (such as masks, tubing, and filters). CPAP rentals contribute to steady, recurring demand, greater price sensitivity, and stronger emphasis on connected devices and service-based differentiation in the U.S. continuous positive airway pressure (CPAP) devices industry.

U.S. Continuous Positive Airway Pressure Devices Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2026 to 2033. For this study, Grand View Research has segmented the U.S. continuous positive airway pressure devices market report based on connectivity and end use.

  • Connectivity Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Connected
    • Bluetooth-Connected CPAP
    • Wi-Fi & Cellular Connected CPAP
    • Hybrid-Connected
  • Non-Connected
  • End Use Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Home Care Settings
  • Hospitals & Clinics
  • Others (Long-Term Care Facilities, etc.)

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
    • 1.4.6. Research Assumption
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. Objectives
    • 1.8.1. Objective - 1
    • 1.8.2. Objective - 2
    • 1.8.3. Objective - 3
  • 1.9. List of Secondary Sources
  • 1.10. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. U.S. CPAP Devices Market
    • 2.1.1. Market Snapshot
    • 2.1.2. Segment Snapshot
      • 2.1.2.1. Connectivity segment outlook
      • 2.1.2.2. End Use segment outlook
    • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Rising incidence of obstructive sleep apnea (OSA)
      • 3.3.1.2. Technological advancements
      • 3.3.1.3. Supportive initiatives by government and private organizations for CPAP devices
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Product recalls & failure
      • 3.3.2.2. Complex regulatory framework pertaining to CPAP devices
    • 3.3.3. Market Opportunity Analysis
      • 3.3.3.1. Growing adoption of CPAP devices in home care settings
    • 3.3.4. Market Challenges Analysis
      • 3.3.4.1. Regulatory and reimbursement challenges
  • 3.4. U.S. CPAP Devices Market Analysis Tools: PESTEL
    • 3.4.1. Political & Legal
    • 3.4.2. Economic & Social
    • 3.4.3. Technology
    • 3.4.4. Environment
  • 3.5. U.S. CPAP Market Analysis Tools: Porter's

Chapter 4. U.S. CPAP Devices Market: Connectivity Estimates & Trend Analysis

  • 4.1. U.S. CPAP Devices Market: Connectivity Movement Analysis
  • 4.2. U.S. CPAP Devices Market: Connectivity Segment Dashboard
  • 4.3. Connectivity Movement & Market Share Analysis, 2025 & 2033
  • 4.4. U.S. Connectivity Market Estimates & Forecast, by Connectivity
  • 4.5. Connected
    • 4.5.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
    • 4.5.2. Bluetooth-Connected CPAP
      • 4.5.2.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
    • 4.5.3. Wi-Fi & Cellular Connected CPAP
      • 4.5.3.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
    • 4.5.4. Hybrid-Connected
      • 4.5.4.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
  • 4.6. Non-Connected
    • 4.6.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)

Chapter 5. U.S. CPAP Devices Market: End Use Estimates & Trend Analysis

  • 5.1. U.S. CPAP Devices Market: End Use Movement Analysis
  • 5.2. U.S. CPAP Devices Market: End Use Segment Dashboard
  • 5.3. End Use Movement & Market Share Analysis, 2025 & 2033
  • 5.4. U.S. CPAP Devices Market Estimates & Forecast, by End Use
  • 5.5. Home Care Settings
    • 5.5.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
  • 5.6. Hospitals & Clinics
    • 5.6.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)
  • 5.7. Others (Long-Term Care Facilities, etc.)
    • 5.7.1. Market Estimates & Forecast, 2021 - 2033 (USD Million) (000' Units)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategies of Market Players for Entry and Exit and Their Impact on Market Competitors
  • 6.3. Company Market Position Analysis
  • 6.4. Company Share Analysis, from 2012 to 2025 (%)
  • 6.5. Company Profiles/Listing
    • 6.5.1. ResMed
      • 6.5.1.1. Overview
      • 6.5.1.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Koninklijke Philips N.V.
      • 6.5.2.1. Overview
      • 6.5.2.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Fisher & Paykel Healthcare Limited
      • 6.5.3.1. Overview
      • 6.5.3.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. React Health (3B Medical)
      • 6.5.4.1. Overview
      • 6.5.4.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Lowenstein Medical
      • 6.5.5.1. Overview
      • 6.5.5.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. BMC Medical
      • 6.5.6.1. Overview
      • 6.5.6.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. Wellell (Apex Medical)
      • 6.5.7.1. Overview
      • 6.5.7.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Armstrong Medical
      • 6.5.8.1. Overview
      • 6.5.8.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Breas Medical
      • 6.5.9.1. Overview
      • 6.5.9.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. SEFAM
      • 6.5.10.1. Overview
      • 6.5.10.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Transcend Inc. (Somnetics International, Inc.)
      • 6.5.11.1. Overview
      • 6.5.11.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Trudell Medical (Vyaire)
      • 6.5.12.1. Overview
      • 6.5.12.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. Medical Depot, Inc. dba Drive DeVilbiss Healthcare
      • 6.5.13.1. Overview
      • 6.5.13.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. Invacare Corporation
      • 6.5.14.1. Overview
      • 6.5.14.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.14.3. Product benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. Apria Healthcare Group LLC
      • 6.5.15.1. Overview
      • 6.5.15.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.15.3. Product benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. Rotech Healthcare Inc.
      • 6.5.16.1. Overview
      • 6.5.16.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.16.3. Product benchmarking
      • 6.5.16.4. Strategic initiatives
    • 6.5.17. Others
      • 6.5.17.1. Overview
      • 6.5.17.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2025)
      • 6.5.17.3. Product benchmarking
      • 6.5.17.4. Strategic initiatives
  • 6.6. U.S CPAP Devices: Sales Model Composition (Rental vs. Direct Purchase), 2020 - 2024
  • 6.7. U.S. PAP Device DME Distributor-Level Profiles
    • 6.7.1. Lincare Holdings Inc.
      • 6.7.1.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.1.2. % contribution of each manufacturer within that DME
      • 6.7.1.3. Sales model mix (% rental vs. direct)
      • 6.7.1.4. Key partnerships and manufacturer
      • 6.7.1.5. Notable strategic changes post-Philips recall
    • 6.7.2. Rotech Healthcare Inc.
      • 6.7.2.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.2.2. % contribution of each manufacturer within that DME
      • 6.7.2.3. Sales model mix (% rental vs. direct)
      • 6.7.2.4. Key partnerships and manufacturer
      • 6.7.2.5. Notable strategic changes post-Philips recall
    • 6.7.3. AdaptHealth
      • 6.7.3.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.3.2. % contribution of each manufacturer within that DME
      • 6.7.3.3. Sales model mix (% rental vs. direct)
      • 6.7.3.4. Key partnerships and manufacturer
      • 6.7.3.5. Notable strategic changes post-Philips recall
    • 6.7.4. Aeroflow Health
      • 6.7.4.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.4.2. % contribution of each manufacturer within that DME
      • 6.7.4.3. Sales model mix (% rental vs. direct)
      • 6.7.4.4. Key partnerships and manufacturer
      • 6.7.4.5. Notable strategic changes post-Philips recall
    • 6.7.5. CPAP.com
      • 6.7.5.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.5.2. % contribution of each manufacturer within that DME
      • 6.7.5.3. Sales model mix (% rental vs. direct)
      • 6.7.5.4. Key partnerships and manufacturer
      • 6.7.5.5. Notable strategic changes post-Philips recall
    • 6.7.6. AHOM
      • 6.7.6.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.6.2. % contribution of each manufacturer within that DME
      • 6.7.6.3. Sales model mix (% rental vs. direct)
      • 6.7.6.4. Key partnerships and manufacturer
      • 6.7.6.5. Notable strategic changes post-Philips recall
    • 6.7.7. The CPAP Shop
      • 6.7.7.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.7.2. % contribution of each manufacturer within that DME
      • 6.7.7.3. Sales model mix (% rental vs. direct)
      • 6.7.7.4. Key partnerships and manufacturer
      • 6.7.7.5. Notable strategic changes post-Philips recall
    • 6.7.8. Sleep Direct
      • 6.7.8.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.8.2. % contribution of each manufacturer within that DME
      • 6.7.8.3. Sales model mix (% rental vs. direct)
      • 6.7.8.4. Key partnerships and manufacturer
      • 6.7.8.5. Notable strategic changes post-Philips recall
    • 6.7.9. Edgepark Medical Supplies
      • 6.7.9.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.9.2. % contribution of each manufacturer within that DME
      • 6.7.9.3. Sales model mix (% rental vs. direct)
      • 6.7.9.4. Key partnerships and manufacturer
      • 6.7.9.5. Notable strategic changes post-Philips recall
    • 6.7.10. Apria Healthcare
      • 6.7.10.1. Estimated CPAP-related revenue and units (2020 - 2024E)
      • 6.7.10.2. % contribution of each manufacturer within that DME
      • 6.7.10.3. Sales model mix (% rental vs. direct)
      • 6.7.10.4. Key partnerships and manufacturer
      • 6.7.10.5. Notable strategic changes post-Philips recall

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. continuous positive airway pressure devices market revenue estimates and forecast, by connectivity, 2021 - 2033 (USD Million) (000' Units)
  • Table 4 U.S. continuous positive airway pressure devices market revenue estimates and forecast, by end use, 2021 - 2033 (USD Million) (000' Units)

List of Figures

  • Fig. 1 U.S. CPAP Devices Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for Market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Technology segment outlook
  • Fig. 11 Application segment outlook
  • Fig. 12 End Use segment outlook
  • Fig. 13 Competitive landscape
  • Fig. 14 U.S. CPAP Devices Market: Market dynamics
  • Fig. 15 U.S. CPAP Devices Market: Porter's analysis
  • Fig. 16 U.S. CPAP Devices Market: PESTLE analysis
  • Fig. 17 U.S. CPAP Devices Market: Connectivity segment dashboard
  • Fig. 18 U.S. CPAP Devices Market: Connectivity movement share analysis
  • Fig. 19 Connected Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 20 Bluetooth-Connected CPAP Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 21 Wi-Fi & Cellular Connected CPAP Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 22 Hybrid-Connected Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 23 Non-Connected Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 24 U.S. CPAP Devices Market: End Use Segment Dashboard
  • Fig. 25 U.S. CPAP Market: End Use Movement Share Analysis
  • Fig. 26 Home Care Settings Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 27 Hospitals & Clinics Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 28 Others (Long-Term Care Facilities, etc) Market, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 29 Company categorization
  • Fig. 30 Company Market Share Analysis (2012 - 2025) Metrics Covered: Unit Volume, Average Selling Price (ASP), Market Value
  • Fig. 31 Strategic framework